Azenta, Inc. (NASDAQ:AZTA) Given Average Rating of “Hold” by Analysts

Azenta, Inc. (NASDAQ:AZTA) has earned an average rating of “Hold” from the eight ratings firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $39.50.

A number of brokerages have weighed in on AZTA. Needham & Company LLC decreased their price target on Azenta from $44.00 to $33.00 and set a “buy” rating for the company in a report on Wednesday, May 6th. Weiss Ratings lowered Azenta from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday, June 29th.

Azenta Stock Performance

NASDAQ:AZTA opened at $25.84 on Friday. Azenta has a 52 week low of $15.93 and a 52 week high of $41.73. The firm’s fifty day moving average is $22.11 and its 200-day moving average is $26.97. The firm has a market cap of $1.19 billion, a P/E ratio of -6.53 and a beta of 1.37.

Azenta (NASDAQ:AZTA) last announced its earnings results on Wednesday, May 6th. The company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.16). The firm had revenue of $144.79 million for the quarter, compared to the consensus estimate of $148.47 million. Azenta had a positive return on equity of 1.23% and a negative net margin of 30.49%.Azenta’s quarterly revenue was up 1.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.01 EPS.

Institutional Investors Weigh In On Azenta

Several large investors have recently modified their holdings of AZTA. Assetmark Inc. grew its stake in shares of Azenta by 54.1% during the 4th quarter. Assetmark Inc. now owns 832 shares of the company’s stock worth $28,000 after acquiring an additional 292 shares during the period. Osaic Holdings Inc. raised its stake in Azenta by 44.9% in the 2nd quarter. Osaic Holdings Inc. now owns 1,242 shares of the company’s stock valued at $39,000 after acquiring an additional 385 shares during the period. CWM LLC lifted its holdings in Azenta by 27.3% during the fourth quarter. CWM LLC now owns 1,822 shares of the company’s stock valued at $61,000 after purchasing an additional 391 shares during the last quarter. Neuberger Berman Group LLC lifted its holdings in Azenta by 6.2% during the third quarter. Neuberger Berman Group LLC now owns 7,695 shares of the company’s stock valued at $221,000 after purchasing an additional 451 shares during the last quarter. Finally, Empowered Funds LLC boosted its position in Azenta by 10.5% during the first quarter. Empowered Funds LLC now owns 6,482 shares of the company’s stock worth $225,000 after purchasing an additional 618 shares during the period. Hedge funds and other institutional investors own 99.08% of the company’s stock.

About Azenta

Azenta, Inc (NASDAQ: AZTA) is a life sciences technology company specializing in sample management, cryogenic storage and genomic services for research and clinical applications. Formerly the Life Sciences division of Brooks Automation, Azenta provides integrated solutions that enable customers to store, track and analyze biological samples with high levels of automation, data integrity and efficiency. Its offerings span automated storage systems, biorepository management software and end‐to‐end sample tracking workflows.

In addition to hardware and informatics platforms for sample storage, Azenta’s Genomics business delivers next‐generation sequencing (NGS), DNA synthesis, and molecular biology services.